FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Mina Sooch, founder and CEO of Ocuphire Pharma, updates the latest research in the development of APX3330 oral tablet to treat retinal disease.
VIDEO: Ocuphire shares latest in oral tablet for treatment of retinal disease
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Mina Sooch, founder and CEO of Ocuphire Pharma, updates the latest research in the development of APX3330 oral tablet to treat retinal disease.